Clinical Trial Update: Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments [NA]

View source ↗

Summary

A Sunnybrook Health Sciences Centre trial is evaluating hyperbaric oxygen therapy for Post-acute COVID-19 syndrome, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute COVID-19 Syndrome

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Post COVID-19 Condition, Post-COVID-19 Syndrome | NA | Status: RECRUITING